Edwards Lifesciences (EW) Tops Q2 EPS by 5c; offers guidance
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $88.26 --0%
EPS Growth %: +10.4%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +10.4%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q2 EPS of $0.67, $0.05 better than the analyst estimate of $0.62. Revenue for the quarter came in at $1.53 billion versus the consensus estimate of $1.49 billion.
GUIDANCE:
Edwards Lifesciences sees FY2025 EPS of $2.40-$2.50, versus the consensus of $2.47.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Starts IQM Quantum Computers (IQMX) at Buy, PT $20
- CLSA Reiterates Outperform (2) Rating on CSL Ltd. (CSL:AU) (CMXHF)
- Citi lowers Hancock Whitney price target to $86
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
